Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Share-based Compensation (2021 - 2025)

Medicinova (MNOV) has disclosed Share-based Compensation for 8 consecutive years, with -$98652.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation changed N/A to -$98652.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $549880.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $829095.0 for FY2025, 30.43% down from the prior year.
  • Share-based Compensation for Q4 2025 was -$98652.0 at Medicinova, down from $157692.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $1.1 million in Q1 2021, with the low at -$756972.0 in Q4 2021.
  • Average Share-based Compensation over 5 years is $245539.1, with a median of $217286.0 recorded in 2023.
  • The sharpest move saw Share-based Compensation tumbled 92.89% in 2022, then soared 397.53% in 2023.
  • Over 5 years, Share-based Compensation stood at -$756972.0 in 2021, then surged by 120.91% to $158298.0 in 2022, then crashed by 249.97% to -$237405.0 in 2023, then skyrocketed by 312.66% to $504862.0 in 2024, then plummeted by 119.54% to -$98652.0 in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at -$98652.0, $157692.0, and $204897.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.